STOCK TITAN

Tanger (SKT) 424B Filings

SKT NYSE

Here are the 424B prospectus supplements from Tanger Inc. (SKT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow SKT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SKT filings page.

Rhea-AI Summary

Tanger Inc. launched an "at-the-market" equity program to offer up to $400,000,000 of common shares. The program, established by a February 26, 2026 sales agreement, permits sales through designated Sales Agents or via forward sale arrangements with Forward Purchasers and Forward Sellers.

The sales may occur on the NYSE or by negotiated transactions, with aggregate sales through the program capped at $400,000,000. The Company stated 114,502,948 common shares were issued and outstanding as of February 18, 2026. Proceeds received from sales made directly through the Sales Agents will accrue to the Company; proceeds from borrowed shares sold by Forward Sellers will be paid to the applicable Forward Purchaser or its affiliates.

Rhea-AI Summary

Tanger Inc. registered the resale of up to 7,370,275 common shares that may be issued upon exchange of $250,000,000 aggregate principal amount of 2.375% Exchangeable Senior Notes due 2031. This registration is made pursuant to a registration rights agreement and covers resale by the selling securityholders if they receive common shares on exchange.

The notes are exchangeable at an initial rate of 24.0662 common shares per $1,000 principal (≈ an exchange price of $41.55 per share). The Operating Partnership may satisfy exchange obligations with cash, common shares or a combination at its election. The Company will receive no proceeds from any resale of these registered shares.